Travere Therapeutics Correlations

TVTX Stock  USD 19.06  0.88  4.84%   
The current 90-days correlation between Travere Therapeutics and Dice Molecules Holdings is 0.06 (i.e., Significant diversification). The correlation of Travere Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Travere Therapeutics Correlation With Market

Modest diversification

The correlation between Travere Therapeutics and DJI is 0.2 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Travere Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Travere Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For more information on how to buy Travere Stock please use our How to Invest in Travere Therapeutics guide.

Moving together with Travere Stock

  0.65KZR Kezar Life SciencesPairCorr
  0.61MLYS Mineralys Therapeutics,PairCorr
  0.71HPQ HP IncPairCorr
  0.69BAC Bank of America Aggressive PushPairCorr
  0.84AA Alcoa Corp Fiscal Year End 15th of January 2025 PairCorr
  0.77INTC Intel Fiscal Year End 23rd of January 2025 PairCorr

Moving against Travere Stock

  0.86VALN Valneva SE ADRPairCorr
  0.81MTEM Molecular TemplatesPairCorr
  0.8NKTX Nkarta IncPairCorr
  0.8AGL agilon healthPairCorr
  0.78MRK Merck Company Fiscal Year End 6th of February 2025 PairCorr
  0.77CYRX CryoportPairCorr
  0.76BACK IMAC HoldingsPairCorr
  0.7IPSC Century Therapeutics Buyout TrendPairCorr
  0.68TPST Tempest TherapeuticsPairCorr
  0.66ME 23Andme HoldingPairCorr
  0.6JNJ Johnson Johnson Sell-off TrendPairCorr
  0.46TCHH Trustcash HoldingsPairCorr
  0.42A Agilent Technologies Sell-off TrendPairCorr
  0.4PFE Pfizer Inc Aggressive PushPairCorr
  0.35MDWD MediwoundPairCorr
  0.91EC Ecopetrol SA ADRPairCorr
  0.8BA Boeing Fiscal Year End 29th of January 2025 PairCorr
  0.68KO Coca Cola Aggressive PushPairCorr
  0.67SHG Shinhan FinancialPairCorr
  0.61HYMTF Hyundai MotorPairCorr
  0.59VFSWW VinFast AutoPairCorr
  0.59TLK Telkom Indonesia TbkPairCorr
  0.47WF Woori Financial GroupPairCorr
  0.34PG Procter GamblePairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
AKRORVMD
RVMDDICE
AKRODICE
COGTVTYX
GPCRVTYX
RNAAKRO
  
High negative correlations   
GPCRDICE
CYTKDICE
RVMDGPCR
RVMDVTYX
VTYXDICE
NUVLDICE

Risk-Adjusted Indicators

There is a big difference between Travere Stock performing well and Travere Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Travere Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
DICE  2.09  0.72  0.30 (0.94) 1.14 
 5.66 
 37.64 
CYTK  1.89 (0.39) 0.00 (0.10) 0.00 
 3.42 
 14.08 
VTYX  3.06 (0.36) 0.00 (0.03) 0.00 
 6.94 
 16.88 
COGT  2.34 (0.24) 0.00 (0.09) 0.00 
 4.58 
 21.15 
NUVL  2.24  0.05  0.04  0.15  2.69 
 3.84 
 36.85 
CERE  0.77  0.07 (0.04) 1.31  0.94 
 1.91 
 6.40 
GPCR  2.96 (0.25) 0.00 (0.23) 0.00 
 8.18 
 24.50 
RVMD  2.00  0.31  0.13  0.39  2.04 
 4.81 
 10.95 
AKRO  2.37  0.03  0.05  0.14  2.82 
 5.23 
 13.37 
RNA  2.89 (0.08) 0.00  0.08  4.19 
 5.78 
 27.94 

Travere Therapeutics Corporate Management

Elizabeth JDGeneral VPProfile
Elizabeth ReedGeneral VPProfile
William RoteSenior DevelopmentProfile
CFA CFAChief OfficerProfile
Angela GiannantonioSenior ResourcesProfile
Jula MDChief OfficerProfile
Casey LoganChief OfficerProfile